Literature DB >> 648630

One step preparation of both human C-reactive protein and CIt.

M Pontet, R Engler, M F Jayle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 648630     DOI： 10.1016/0014-5793(78)80167-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  9 in total

1.  Differentiation of circulating monocytes into fibroblast-like cells.

Authors:  Darrell Pilling; Richard H Gomer
Journal:  Methods Mol Biol       Date:  2012

2.  Binding of serum amyloid P-component (SAP) by amyloid fibrils.

Authors:  M B Pepys; R F Dyck; F C de Beer; M Skinner; A S Cohen
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

3.  Analytical and clinical validation of a time-resolved immunofluorometric assay (TR-IFMA) for canine C-reactive protein in serum.

Authors:  M D Parra; M Tuomola; J Cabezas-Herrera; J J Cerón
Journal:  Vet Res Commun       Date:  2006-02       Impact factor: 2.459

4.  Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.

Authors:  D M Vigushin; M B Pepys; P N Hawkins
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  C-reactive protein protects against preerythrocytic stages of malaria.

Authors:  S Pied; A Nussler; M Pontent; F Miltgen; H Matile; P H Lambert; D Mazier
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

6.  Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.

Authors:  P N Hawkins; M J Myers; A A Epenetos; D Caspi; M B Pepys
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

7.  Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro.

Authors:  Daisaku Ozawa; Ryo Nomura; P Patrizia Mangione; Kazuhiro Hasegawa; Tadakazu Okoshi; Riccardo Porcari; Vittorio Bellotti; Hironobu Naiki
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

8.  Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use.

Authors:  Mark B Pepys; J Ruth Gallimore; Joanne Lloyd; Zhanhong Li; David Graham; Graham W Taylor; Stephan Ellmerich; Palma P Mangione; Glenys A Tennent; Winston L Hutchinson; David J Millar; Gary Bennett; John More; David Evans; Yogesh Mistry; Stephen Poole; Philip N Hawkins
Journal:  J Immunol Methods       Date:  2012-07-31       Impact factor: 2.303

9.  Interaction of serum amyloid P component with hexanoyl bis(D-proline) (CPHPC).

Authors:  Simon E Kolstoe; Michelle C Jenvey; Alan Purvis; Mark E Light; Darren Thompson; Peter Hughes; Mark B Pepys; Stephen P Wood
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-07-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.